362 related articles for article (PubMed ID: 20155985)
1. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
Myung JH; Launiere CA; Eddington DT; Hong S
Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
[TBL] [Abstract][Full Text] [Related]
2. Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.
Mitchell MJ; Castellanos CA; King MR
J Biomed Mater Res A; 2015 Oct; 103(10):3407-18. PubMed ID: 25761664
[TBL] [Abstract][Full Text] [Related]
3. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
[TBL] [Abstract][Full Text] [Related]
5. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
6. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
7. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
Johnson ES; Anand RK; Chiu DT
Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
[TBL] [Abstract][Full Text] [Related]
8. Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application.
Bu J; Nair A; Kubiatowicz LJ; Poellmann MJ; Jeong WJ; Reyes-Martinez M; Armstrong AJ; George DJ; Wang AZ; Zhang T; Hong S
Biosens Bioelectron; 2020 Aug; 162():112250. PubMed ID: 32392161
[TBL] [Abstract][Full Text] [Related]
9. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
10. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
[TBL] [Abstract][Full Text] [Related]
11. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
[TBL] [Abstract][Full Text] [Related]
12. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
13. Channel surface patterning of alternating biomimetic protein combinations for enhanced microfluidic tumor cell isolation.
Launiere C; Gaskill M; Czaplewski G; Myung JH; Hong S; Eddington DT
Anal Chem; 2012 May; 84(9):4022-8. PubMed ID: 22482510
[TBL] [Abstract][Full Text] [Related]
14. Size-selective collection of circulating tumor cells using Vortex technology.
Sollier E; Go DE; Che J; Gossett DR; O'Byrne S; Weaver WM; Kummer N; Rettig M; Goldman J; Nickols N; McCloskey S; Kulkarni RP; Di Carlo D
Lab Chip; 2014 Jan; 14(1):63-77. PubMed ID: 24061411
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials.
Xie J; Gao Y; Zhao R; Sinko PJ; Gu S; Wang J; Li Y; Lu Y; Yu S; Wang L; Chen S; Shao J; Jia L
J Control Release; 2015 Jul; 209():159-69. PubMed ID: 25933713
[TBL] [Abstract][Full Text] [Related]
16. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
Hyun KA; Lee TY; Lee SH; Jung HI
Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood.
Park JM; Lee JY; Lee JG; Jeong H; Oh JM; Kim YJ; Park D; Kim MS; Lee HJ; Oh JH; Lee SS; Lee WY; Huh N
Anal Chem; 2012 Sep; 84(17):7400-7. PubMed ID: 22881997
[TBL] [Abstract][Full Text] [Related]
18. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
20. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
